New! Sign up for our free email newsletter.
Science News
from research organizations

Fungus-fighting compound found in Drug Discovery Center Library

Date:
September 22, 2016
Source:
Virginia Tech
Summary:
A compound has been found that blocks the growth of a fungus that causes deadly lung infections and allergic reactions in people with compromised immune systems.
Share:
FULL STORY

Researchers with the Virginia Tech Center for Drug Discovery have identified a compound that blocks the growth of a fungus that causes deadly lung infections and allergic reactions in people with compromised immune systems.

The research team targeted the switch that allows the fungus Aspergillus fumigatus to survive in iron-deficient conditions like the human body. Specifically, they targeted an enzyme known as SidA, which is essential for the synthesis of molecules called siderophores that are made during infection to steal iron from human proteins.

Furthermore, by performing high-throughput screening in the center's Drug Discovery Screening Laboratory, they found a compound called Celastrol that blocks the growth of iron-producing organelles in the fungus.

The results were published in the journal ACS Chemical Biology.

"This project shows what an asset the screening lab is to the community," said Pablo Sobrado, a professor of biochemistry in the College of Agriculture and Life Sciences and director of the screening laboratory. "Without the robots and chemical libraries available at the screening lab, this work would not have been possible. We are very fortunate at Virginia Tech to have this facility."

Aspergillus fumigatus is common and is typically found in soil and decaying organic matter. Most people are exposed to it daily with little consequence, but it can cause lung damage in people with compromised immune systems, such as organ transplant recipients and people with AIDS or leukemia. The mortality rate of this population, when exposed to the fungus, is more than 50 percent, according to the authors.

"Growing antibiotic resistance is demanding the development of target-directed therapies," said Julia S. Martin del Campo, a postdoctoral research scientist in Sobrado's lab. "This approach requires the discovery of enzyme inhibitors that block essential pathogen pathways. The discovery of Celastrol as a SidA inhibitor represents the first building block in the development of drugs against A. fumigatus and related pathogens."


Story Source:

Materials provided by Virginia Tech. Note: Content may be edited for style and length.


Journal Reference:

  1. Julia S. Martín del Campo, Nancy Vogelaar, Karishma Tolani, Karina Kizjakina, Kim Harich, Pablo Sobrado. Inhibition of the Flavin-Dependent Monooxygenase Siderophore A (SidA) Blocks Siderophore Biosynthesis and Aspergillus fumigatus Growth. ACS Chemical Biology, 2016; DOI: 10.1021/acschembio.6b00666

Cite This Page:

Virginia Tech. "Fungus-fighting compound found in Drug Discovery Center Library." ScienceDaily. ScienceDaily, 22 September 2016. <www.sciencedaily.com/releases/2016/09/160922095856.htm>.
Virginia Tech. (2016, September 22). Fungus-fighting compound found in Drug Discovery Center Library. ScienceDaily. Retrieved March 28, 2024 from www.sciencedaily.com/releases/2016/09/160922095856.htm
Virginia Tech. "Fungus-fighting compound found in Drug Discovery Center Library." ScienceDaily. www.sciencedaily.com/releases/2016/09/160922095856.htm (accessed March 28, 2024).

Explore More

from ScienceDaily

RELATED STORIES